Generics Drugs Market Research Reports & Industry Analysis
The Federal Drug Administration (FDA) does not allow a generic firm to duplicate exactly the brand name formula. The generic manufacturer must alter the ingredients slightly. This is accomplished by adding inert substances, substances that are inactive, to the generic alternative. Inert substances may function as disintegrates, binders, fillers, drying agents, lubricants, coatings, wetting agents, flavorings, coloring, or drying agents. Generic drugs are often up to 50 to 80 percent cheaper than their brand name counterpart and are gaining in popularity among cost-conscious consumers and their third-party payers.
Generic drugs enter into the retail prescription industry in a two-step process. The exclusive patent protection for the brand name product must expire. As a brand name product nears patent expiration, generic competitors apply for approval to the FDA using an Abbreviated New Drug Application (ANDA). Duplicating studies of the original brand name drug is no longer required by the FDA, and many generic companies contract with specialty laboratories to conduct the bioequivalency studies regarding absorption rates. Although the majority of products must meet bioequivalence standards, bronchodilators and topical drugs cannot be measured by absorption rates and are exempt. Injectables do not require biostudies, and oral liquids are reviewed on an individual basis. The drug must receive FDA approval following this rigid testing. The FDA also conducts periodic plant site inspections and surveillance of quality control procedures.
Generics Drugs Industry Research & Market Reports
-
International Directory of Generics Companies 2023
... 2023 This Directory is your connection to key decision-makers in the Generics industry in Europe, the Americas, the Asia & Pacific region, the Middle East & Africa.Extensive profiles of companies and each company's senior officials. Read More
-
Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drugs [Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, sGC Stimulators, and pde-5 Dipsticks], Type (Branded and Generics), Route of Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies)
... Administration (Oral, Intravenous/Subcutaneous, and Inhalational), and Distribution Channel (Hospital Pharmacies and Clinics, Online Pharmacies, and Retail Pharmacies) The pulmonary arterial hypertension market is expected to grow from US$ 7,369.89 million in 2021 to US$ 10,889.08 ... Read More
-
High Potency APIs (HPAPIs)
... this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation ... Read More
-
Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global generic injectable market by segmenting the market based ... Read More
-
Global Generic drugs Market 2023-2027
... Our report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormones, Cytokines), Drug (OTC,Rx) Application (Diabetes, Oncology, CVD) - Global Forecast to 2027
... (APIs) market is estimated to reach USD 145.9 billion by 2022 to USD 216.4 billion in 2027, at a CAGR of 8.2% during the forecast period. Factors such as the increasing uptake of biopharmaceuticals, the ... Read More
-
Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)
... Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others) The malaria treatment market is expected to grow from US$ 1,638.27 million in 2021 ... Read More
-
United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape
... States generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by ... Read More
-
Pharmaceuticals Industry in India - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... The India Pharmaceutical Industry has emerged as greater power amid COVID-19. The growth of the India Pharmaceutical industry is largely supported by the government. The emergence of COVID-19 has led to the health crisis that ... Read More
-
Norway Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... significant impact on the pharmaceutical and healthcare industry in Norway. As per the article published in 2020 under the title “The COVID-19 pandemic in Norway and Sweden – threats, trust, and impact on daily life: ... Read More
-
Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
... US$ 28.1 Billion by 2027, exhibiting a growth rate (CAGR) of 8.86% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence ... Read More
-
Generic Oncology Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
... to reach US$ 36.9 Billion by 2027, exhibiting a growth rate (CAGR) of 5.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the ... Read More
-
Global Inhalation & Nasal Sprays Generic Drugs Market (2022-2027) by Indication, Patient Demographics, Drug Class, Distribution Channel, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
... Generic Drugs Market is estimated to be USD 8.06 Bn in 2022 and is expected to reach USD 11.81 Bn by 2027, growing at a CAGR of 7.94%. Market Dynamics Market dynamics are forces that ... Read More
-
Generic Drugs Markets in China
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More
-
Generic Drugs Companies in China
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
Generic Drugs Industry Forecasts - China Focus
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Active Pharmaceutical Ingredients (API)
... Billion in the year 2020, is projected to reach a revised size of US$264.1 Billion by 2027, growing at aCAGR of 6% over the period 2020-2027. Innovative, one of the segments analyzed in the report, ... Read More
-
Prescription Drugs
... a revised size of US$1.7 Trillion by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027. Generics, one of the segments analyzed in the report, is projected to record a 7.1% CAGR ... Read More
-
Generic and Biosimilar Pharmaceuticals (GLOBAL) - Industry Report
... on the top 1110 companies, including ABBOTT LABORATORIES, ABBOTT LABORATÓRIOS, LDA and ACG LUKAPS D.O.O.. This report covers activities such as pharmaceuticals, drugs, medicines, pills, healthcare and includes a wealth of information on the financial ... Read More
-
Efficacy Testing
... projected to reach a revised size of US$866.3 Million by 2027, growing at a CAGR of 10.7% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record ... Read More
-
Inhalation and Nasal Spray Generic Drugs
... Spray Generic Drugs estimated at US$26.6 Billion in the year 2020, is projected to reach a revised size of US$38 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. Corticosteroids, ... Read More
-
Specialty Generics
... projected to reach a revised size of US$125.6 Billion by 2027, growing at aCAGR of 10.5% over the period 2020-2027. Injectables, one of the segments analyzed in the report, is projected to record 11.3% CAGR ... Read More
-
Global Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028)
... at USD 9925.16 Million in the year 2021. Acne Treatment Market growth is primarily driven by factors such as a rapid surge in the young population, rising demand for personal wellness and smooth spotless skin ... Read More
-
Pharma Wholesale and Distribution Market Report 2022-2032
... the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Pharmaceutical Wholesaler and Distributor Anticipated ... Read More
-
North America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in ... Read More
Research Assistance
